Determination of the dose of agomelatine, a melatoninergic agonist and the selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study - Lôo, H; Hale, A; D’Haenen, H (Int Clin Psychopharmacol., 2002)